SUBSCRIBE
SUBSCRIBE

Radius Health

NEWS
Scandal-Ridden Proove Biosciences Sells Assets, Founder and CEO Exits Amid Allegations
Business
Radius Health’s Longtime CEO Out, Former Novo Nordisk A/S Exec Named New Leader
July 17, 2017
 · 
2 min read
Wall Street's Top Biotech Analyst Loves These 2 Life Science Stocks
Biotech Beach
3 High-Risk, High-Reward Biotech Stocks
August 24, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Radius Health May Be Acquisition Target for Shire Based on Its Osteoporosis Pipeline
August 11, 2016
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
BioMidwest
3 Biotech Stocks That Could Explode in the Next 12 Months
July 20, 2016
 · 
2 min read
Doing it Right: The Man Who Blew Up Theranos Started His Own Medical Testing Biotech
Job Trends
Massachusetts-Based Radius Health Opens Up Shop in Philadelphia with Plans to Hire 100+ Employees
June 22, 2016
 · 
2 min read
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
Drug Development
10 Massachusetts Biotechs that Grew Their Headcount by at Least 40% in 2015
March 23, 2016
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Policy
Five Companies Face Big FDA Decisions This Month
March 14, 2016
 · 
3 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Job Trends
Radius Health Delays Osteoporosis Drug Application in the U.S. to Avoid Rush, Respect Staffers’ Holidays
November 18, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
While Baxalta Bid Simmers on the Back Burner, Shire Rumored to Be Eying Radius Health Acquisition
October 19, 2015
 · 
3 min read
Load More
JOBS
IN THE PRESS
Genetown
Radius Announces Royalty Purchase Agreement With DRI Healthcare to Sell a Portion of Its Royalty and Commercial Milestone Interest in elacestrant for up to $140 Million
August 14, 2023
 · 
3 min read
FDA
Radius Health’s TYMLOS® (abaloparatide) Receives U.S. FDA Approval as a Treatment to Increase Bone Density in Men with Osteoporosis at High Risk for Fracture
December 20, 2022
 · 
9 min read
Drug Development
Radius Announces First Patient Randomized in the RAD011 Pivotal Trial for Prader-Willi Syndrome
July 7, 2022
 · 
5 min read
Policy
Menarini Group and Radius Health Submit New Drug Application to the U.S. FDA for Elacestrant
June 22, 2022
 · 
8 min read
Genetown
Radius Health Update on Abaloparatide Transdermal System
June 1, 2022
 · 
6 min read
Drug Development
Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology
May 19, 2022
 · 
9 min read
Business
Radius Health, Inc. First Quarter 2022 Results
May 5, 2022
 · 
23 min read
Business
Radius Health to Release First Quarter 2022 Financial Results, Host Conference Call and Live Webcast on Thursday, May 5, 2022
April 25, 2022
 · 
1 min read
Business
Radius Health Announces Leadership Appointments
March 16, 2022
 · 
2 min read
Genetown
Radius Health Provides Business Update on Bone Health
March 8, 2022
 · 
6 min read
Load More